Stockreport

ESPR to Boost Cardiovascular Portfolio With Corstasis Buyout for $75M [Yahoo! Finance]

DAIICHI SANKYO S/ADR  (DSNKY) 
PDF Esperion Therapeutics ESPR announced that it has entered into a definitive agreement to acquire Nevada-based, privately held, commercial-stage biopharmaceutical company [Read more]